EFFICACY AND SAFETY OF ELAFIBRANOR IN PRIMARY BILIARY CHOLANGITIS: RESULTS FROM THE ELATIVE™ DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED PHASE 3 TRIAL
Christopher L Bowlus, Kris V Kowdley, Cynthia Levy, Ulus Akarca, Mario Reis Alvares-Da-Silva, Pietro Andreone and Marco Arrese
EFFICACY AND SAFETY OF ELAFIBRANOR IN PRIMARY BILIARY CHOLANGITIS: RESULTS FROM THE ELATIVE™ DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED PHASE 3 TRIAL
Creators
Christopher L Bowlus
Kris V Kowdley
Cynthia Levy
Ulus Akarca
Mario Reis Alvares-Da-Silva
Pietro Andreone
Marco Arrese
Publisher
Lippincott Williams & Wilkins
Academic Unit
Miller School of Medicine; UMMG Dept of Medicine - Hepatology